Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen N Davis

Showing results (31-40 of 127) with videos related to

Pageof 13
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|August 30, 2017
The care of pregestational and gestational diabetes and drug metabolism considerationsMaka S Hedrington, Stephen N Davis
The Diabetes Educator|July 13, 2006
Psychological insulin resistance: overcoming barriers to starting insulin therapyStephen N Davis, Susan M Renda
Clinical Chemistry|October 27, 2010
Hypoglycemia and vascular diseaseLisa M Younk, Stephen N Davis
Frontiers in Endocrinology|May 13, 2015
Sexual Dimorphism in Glucose and Lipid Metabolism during Fasting, Hypoglycemia, and ExerciseMaka S Hedrington, Stephen N Davis
Current Diabetes Reports|March 28, 2008
Endocannabinoid system overactivity and the metabolic syndrome: prospects for treatmentJennifer M Perkins, Stephen N Davis
Current Opinion in Endocrinology, Diabetes, and Obesity|March 5, 2008
The renin-angiotensin-aldosterone system: a pivotal role in insulin sensitivity and glycemic controlJennifer M Perkins, Stephen N Davis
Expert Opinion on Pharmacotherapy|December 1, 2018
Oral semaglutide for the treatment of type 2 diabetesMaka S Hedrington, Stephen N Davis
Therapeutics and Clinical Risk Management|May 23, 2015
The role of empagliflozin in the management of type 2 diabetes by patient profileMaka S Hedrington, Stephen N Davis
Nature Clinical Practice. Endocrinology & Metabolism|September 13, 2007
Diabetic ketoacidosis in type 2 diabetes mellitus--pathophysiology and clinical presentationStephen N Davis, Guillermo E Umpierrez
Expert Opinion on Investigational Drugs|September 25, 2014
Discontinued in 2013: diabetic drugsMaka S Hedrington, Stephen N Davis
Pageof 13

Showing results (31-40 of 127) with videos related to

Sort By:
Pageof 13
Expert Opinion on Drug Metabolism & Toxicology|August 30, 2017
The care of pregestational and gestational diabetes and drug metabolism considerationsMaka S Hedrington, Stephen N Davis
The Diabetes Educator|July 13, 2006
Psychological insulin resistance: overcoming barriers to starting insulin therapyStephen N Davis, Susan M Renda
Clinical Chemistry|October 27, 2010
Hypoglycemia and vascular diseaseLisa M Younk, Stephen N Davis
Frontiers in Endocrinology|May 13, 2015
Sexual Dimorphism in Glucose and Lipid Metabolism during Fasting, Hypoglycemia, and ExerciseMaka S Hedrington, Stephen N Davis
Current Diabetes Reports|March 28, 2008
Endocannabinoid system overactivity and the metabolic syndrome: prospects for treatmentJennifer M Perkins, Stephen N Davis
Current Opinion in Endocrinology, Diabetes, and Obesity|March 5, 2008
The renin-angiotensin-aldosterone system: a pivotal role in insulin sensitivity and glycemic controlJennifer M Perkins, Stephen N Davis
Expert Opinion on Pharmacotherapy|December 1, 2018
Oral semaglutide for the treatment of type 2 diabetesMaka S Hedrington, Stephen N Davis
Therapeutics and Clinical Risk Management|May 23, 2015
The role of empagliflozin in the management of type 2 diabetes by patient profileMaka S Hedrington, Stephen N Davis
Nature Clinical Practice. Endocrinology & Metabolism|September 13, 2007
Diabetic ketoacidosis in type 2 diabetes mellitus--pathophysiology and clinical presentationStephen N Davis, Guillermo E Umpierrez
Expert Opinion on Investigational Drugs|September 25, 2014
Discontinued in 2013: diabetic drugsMaka S Hedrington, Stephen N Davis
Pageof 13